2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the …

K Zeppenfeld, J Tfelt-Hansen, M De Riva… - European heart …, 2022 - academic.oup.com
4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Sarcoidosis: Epidemiology and clinical insights

M Rossides, P Darlington, S Kullberg… - Journal of internal …, 2023 - Wiley Online Library
Sarcoidosis is characterized by noncaseating granulomas which form in almost any part of
the body, primarily in the lungs and/or thoracic lymph nodes. Environmental exposures in …

JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis―Digest version―

F Terasaki, A Azuma, T Anzai, N Ishizaka… - Circulation …, 2019 - jstage.jst.go.jp
Sarcoidosis is a systemic granulomatous disease of unknown cause. Sarcoidosis involving
the heart, ie, cardiac sarcoidosis, affects the prognosis of patients significantly as it may lead …

Cardiac sarcoidosis

DH Birnie, PB Nery, AC Ha, RSB Beanlands - Journal of the American …, 2016 - jacc.org
Clinically manifest cardiac involvement occurs in perhaps 5% of patients with sarcoidosis.
The 3 principal manifestations of cardiac sarcoidosis (CS) are conduction abnormalities …

Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review

MG Trivieri, P Spagnolo, D Birnie, P Liu… - Journal of the American …, 2020 - jacc.org
Sarcoidosis is a complex disease with heterogeneous clinical presentations that can affect
virtually any organ. Although the lung is typically the most common organ involved …

Inflammatory cardiomyopathic syndromes

BH Trachtenberg, JM Hare - Circulation research, 2017 - ahajournals.org
Inflammatory activation occurs in nearly all forms of myocardial injury. In contrast,
inflammatory cardiomyopathies refer to a diverse group of disorders in which inflammation of …

Sarcoidosis: causes, diagnosis, clinical features, and treatments

R Jain, D Yadav, N Puranik, R Guleria… - Journal of clinical medicine, 2020 - mdpi.com
Sarcoidosis is a multisystem granulomatous disease with nonspecific clinical manifestations
that commonly affects the pulmonary system and other organs including the eyes, skin, liver …

Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation

E Criado, M Sánchez, J Ramírez, P Arguis… - Radiographics, 2010 - pubs.rsna.org
Sarcoidosis is a multisystem disorder that is characterized by noncaseous epithelioid cell
granulomas, which may affect almost any organ. Thoracic involvement is common and …

A case control etiologic study of sarcoidosis: environmental and occupational risk factors

LS Newman, CS Rose, EA Bresnitz… - American journal of …, 2004 - atsjournals.org
Past research suggests that environmental factors may be associated with sarcoidosis risk.
We conducted a case control study to test a priori hypotheses that environmental and …

Sarcoidosis epidemiology: race matters

KM Hena - Frontiers in immunology, 2020 - frontiersin.org
Rather than a single disease entity, sarcoidosis may be a constellation of “sarcoidoses” with
a characteristic pattern of organ involvement and clinic course, depending upon the …